Frequently Asked Questions
-
What value is the oral dissolving film market expected to touch by 2032?
The global oral dissolving film market size was USD 0.39 billion in 2023 and is projected to grow from USD 0.43 billion in 2024 to USD 0.92 billion by 2032.
-
What CAGR is the oral dissolving film market expected to exhibit by 2032?
The oral dissolving film market is expected to exhibit a CAGR of 9.6% by 2032.
-
What are the segments of the oral dissolving film market?
By type, the oral dissolving film market is segmented into oromucosal film and orodispersible film. Based on application, the market is classified into hospitals and clinics, drug stores, and e-commerce.
-
Which are the driving factors of the oral dissolving film market?
Government’s emphasis on development of advanced healthcare facilities to surge growth and the rapid adoption of the product to boost product demand are the factors driving the oral dissolving film market.
-
Which are the top companies operating in the oral dissolving film market?
Aquestive Therapeutics, Kyukyu Pharmaceutical, BioDelivery(BDSI), IntelGenx, Tapemark, Shilpa Therapeutics CL Pharm, Lubrizol Life Science, Adhex Pharma, DK Livkon, Arx Pharma, Aavishkar, ZIM Laboratories, Umang Pharmaceuticals, and Cure Pharmaceutical are the top companies operating in the oral dissolving film market.